-
An oral selective phosphodiesterase 4 (pde4) inhibi-tor has been approved for the treatment of patients with chronic obstructive pulmonary disease (COPD). Roflumilast is the first drug of this type to be approved for this indication. It is marketed by Forest Pharmaceuticals as Daliresp.
-
-
The health improvement network UK primary care database was queried for all patients aged 50-84 who were prescribed low-dose aspirin (75-300 mg/day) for the secondary prevention of cardiovascular disease in 2000-2007.
-
The 2006 Centers for Disease Control and Prevention (CDC) sexually transmitted disease (STD) guidelines have been updated.
-
People who are told by their physicians that they are overweight or obese are more likely to identify themselves as such, more likely to want to lose weight, and more likely to try.
-
-
-
The ECG above was obtained in the office from a 47-year-old woman who said she had "heart problems" that resulted in hospitalization the month before.
-
The action to control cardiovascu-lar risk in diabetes (ACCORD) study is really three studies in one, providing information about blood pressure, glucose, and triglyceride treatment in high-risk diabetic patients.
-
The FDA has approved the first new treatment for systemic lupus erythematosus (SLE) since 1955 when hydroxychloroquine and corticosteroids were approved. Belimumab is a recombinant human IgG1l monoclonal antibody specific for soluble human B lymphocyte stimulator protein (BLyS).